2018
DOI: 10.1111/1475-6773.12869
|View full text |Cite
|
Sign up to set email alerts
|

The Impact of the Hospital Readmissions Reduction Program across Insurance Types in California

Abstract: Post-HRRP, greater than expected reductions occurred in rehospitalizations for patients with Medicare FFS and Medicare MC. HRRP incentives may be influencing system-wide changes influencing care outside of traditional Medicare.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
10
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(12 citation statements)
references
References 24 publications
1
10
0
Order By: Relevance
“…However, the precise mechanisms underlying this trend are unclear. Although this pattern could be consistent with anticipatory and spillover effects of the HRRP on all patients treated within the same HRRP-eligible hospitals 30,31 , it may also be consistent with the mounting evidence that broad declines in readmissions since the passage of the U.S. Affordable Care Act may be attributable to factors beyond the threat of HRRP penalties [32][33][34][35][36][37] .…”
Section: Discussionsupporting
confidence: 64%
See 1 more Smart Citation
“…However, the precise mechanisms underlying this trend are unclear. Although this pattern could be consistent with anticipatory and spillover effects of the HRRP on all patients treated within the same HRRP-eligible hospitals 30,31 , it may also be consistent with the mounting evidence that broad declines in readmissions since the passage of the U.S. Affordable Care Act may be attributable to factors beyond the threat of HRRP penalties [32][33][34][35][36][37] .…”
Section: Discussionsupporting
confidence: 64%
“…These studies demonstrated declines in surgical readmission rates since at least 2008; however, much of these declines occurred prior to the actual implementation of the HRRP penalties for total hip and knee replacement readmissions. Furthermore, the use of patient-level control groups from the same hospital in these studies makes it difficult to rule out HRRP-associated spillover effects 30,31 and thus determine the direct effect of the HRRP penalties. Our study addressed this concern by exploiting hospital-level variation in the relative size of potential HRRP penalties.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, there are worries that hospitals may use triage methods to reduce readmissions, as well as increase the number of patients that are admitted for observation when an admission is warranted (Gupta & Fonarow, ). Regardless, published studies have been divisive in terms of the effectiveness of the HRRP in reducing 30‐day readmission rates, particularly in regard to HF patients (Gupta et al, ; Gupta & Fonarow, ; Lu, Huang, & Johnson, ; Wasfy et al, ; Zingmond, Liang, Parikh, & Escarce, ; Zohrabian, Kapp, & Simoes, ). Currently, an increasing number of studies are being done to look at whether 30‐day readmission rates are suitable for diseases other than HF, acute MI and pneumonia, one of which is aneurysmal subarachnoid hemorrhages (SAHs).…”
Section: Thirty‐day Readmission As a Quality Indicatormentioning
confidence: 99%
“…Recent studies have evaluated the overall effects of the HRRP on readmissions at both the state (Carey & Lin, 2015; Chen & Grabowski, 2017; McGarry, Blankley, & Li, 2016; Mellor, Daly, & Smith, 2017; Zingmond, Liang, Parikh, & Escarce, 2018) and national levels (Gupta, 2017) using discharge or claims data. These studies generally show that the implementation of the HRRP is associated with a decrease in readmission rates among Medicare beneficiaries with the targeted conditions (i.e., AMI, CHF, PN, COPD, elective joint replacement).…”
Section: Introductionmentioning
confidence: 99%
“…However, the reductions in readmission rates appear to be the greatest and the most consistent for AMI, with estimated reductions in readmission rates ranging around 1 to 4 percentage points between pre- and postimplementation periods. Some studies find significant reductions in readmission rates due to heart failure (Carey & Lin, 2015; Chen & Grabowski, 2017; Gupta, 2017; Zingmond et al, 2018) and PN (Zingmond et al, 2018) but with smaller magnitudes in comparison with AMI. While some authors find no dose–response relationship between the risk and the amount of penalty (McGarry et al, 2016), others (Gupta, 2017; Mellor et al, 2017) find evidence of such a relationship using quasi-experimental econometric methods.…”
Section: Introductionmentioning
confidence: 99%